Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies James T. Parsons files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Bernd R. Seizinger - $187K in ONCY purchases and sales in the last 12 months
- Jared Kelly - $34K in ONCY purchases and sales in the last 12 months
- Patricia S. Andrews - $30K in ONCY purchases and sales in the last 12 months
- Andrew Aromando - $25K in ONCY purchases and sales in the last 12 months
- Wayne Pisano - $25K in ONCY purchases and sales in the last 12 months
- Deborah Margaret Brown - $21K in ONCY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is James T. Parsons?
James T. Parsons is a corporate insider of DiaMedica Therapeutics Inc. (DMAC). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did James T. Parsons last file a Form 4?
The most recent primary Form 4 on record is dated 3 June 2026, one of 4 filings going back to 2025.
Has James T. Parsons been buying or selling stock?
Recorded transactions: 1 open-market purchase ($10K) and 0 open-market sales across all tracked filings.
